🇺🇸 FDA
Pipeline program

Shenfu Injection

D99-2015(043)-TCM-4

Approved small_molecule completed

Quick answer

Shenfu Injection for Myocardial Infarction is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Myocardial Infarction
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials